Adapthealth Corp. (AHCO) Stock Price & Analysis

Adapthealth Corp. (AHCO) rose 2.77% to USD 10.76 as of July 25, 2026 at 03:52 UTC, according to Nexqual real-time market data.

AHCO last closed at USD 10.47; the session ranged USD 10.47–10.9 on volume of 821,520 shares. Market capitalization is $1.46B, with a 52-week range of USD 8.51–13.43 (NCM). Source: Nexqual, July 25, 2026 at 03:52 UTC.

Key Statistics (as of July 25, 2026 at 03:52 UTC)

PriceUSD 10.76
Change▲ 2.77% (up)
Previous CloseUSD 10.47
OpenUSD 10.63
Day RangeUSD 10.47 – 10.9
52-Week RangeUSD 8.51 – 13.43
Volume821,520 shares
Market Cap$1.46B
ExchangeNCM

Technical Analysis (AHCO)

Nexqual's technical model rates AHCO "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 03:52 UTC.

Overall SignalSTRONG BUY
RSI (14)55.92 (neutral)
vs SMA50Above (USD 10.27)
MACD0.15 (positive)

Analyst Ratings (AHCO)

Wall Street analysts rate AHCO "Strong Buy" based on 7 analysts, with a mean price target of USD 14.14 (range USD 12–16), per Nexqual as of July 25, 2026 at 03:52 UTC.

Consensus RatingStrong Buy
Analyst Count7
Mean TargetUSD 14.14
High TargetUSD 16
Low TargetUSD 12
Buy / Hold / Sell7 / 0 / 0

Earnings (AHCO)

Next Earnings Date2026-08-04
EPS EstimateUSD 0.17
Revenue Estimate$846.77M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD -0.05 vs est 0.01 ▼ miss
2025-12-31USD 0.27 vs est 0.34 ▼ miss
2025-09-30USD 0.23 vs est 0.24 ▼ miss
2025-06-30USD 0.07 vs est 0.16 ▼ miss

Source: Nexqual, July 25, 2026 at 03:52 UTC.

Financials & Fundamentals (AHCO)

Total Revenue$3.29B
Revenue Growth (YoY)+5.40%
Gross Margin+20.40%
Operating Margin+0.67%
Profit Margin-2.42%
ROE-4.85%
Debt / Equity132.11
Current Ratio0.93
Total Cash$47.96M
Total Debt$2.00B
Free Cash Flow$267.90M

Source: Nexqual, July 25, 2026 at 03:52 UTC.

Financial Health Score (AHCO)

Nexqual rates Adapthealth Corp.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 03:52 UTC.

GrowthWeak — Revenue -0% YoY (annual), declining
ProfitabilityWeak — Gross margin 20%, operating 1%
Balance SheetWeak — $48M cash vs $2.00B debt
Cash FlowSolid — FCF $268M, 8% margin
EfficiencyCritical — ROE -5%, ROA 2.6%

Ownership (AHCO)

Insider Ownership+8.14%
Institutional Ownership+106.66%
Shares Outstanding136.05M
Float85.56M
Short % of Float+7.83%

Source: Nexqual, July 25, 2026 at 03:52 UTC.

Leadership (AHCO)

Adapthealth Corp. is led by Suzanne M. Foster M.P.H. (age 55), CEO & Director, per Nexqual as of July 25, 2026 at 03:52 UTC.

CEO & DirectorSuzanne M. Foster M.P.H. (age 55)
Chief Financial OfficerJason A. Clemens C.F.A. (age 46)
CTO & Chief Innovation OfficerAlbert A. Prast (age 65)

Major Backers & Investors (AHCO)

Notable institutional backers of Adapthealth Corp. include OEP Capital Advisors, LP, Deerfield Management Company, L.P, Skyknight Capital, L.p., according to Nexqual as of July 25, 2026 at 03:52 UTC.

Active Investors

InvestorStake
OEP Capital Advisors, LP11.99%
Deerfield Management Company, L.P8.44%
Skyknight Capital, L.p.6.31%
FMR, LLC5.92%
Reinhart Partners, LLC5.45%
Fidelity3.06%

Index Funds (Passive)

FundStake
BlackRock18.3%
Vanguard Group13.8%
Dimensional Fund Advisors5.09%
State Street3.16%

Source: Nexqual, July 25, 2026 at 03:52 UTC.

From Adapthealth Corp.'s Latest SEC 10-K Filing (filed 2026-02-24)

Key Strengths & Strategy (as disclosed to the SEC)

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
OPCHOption Care Health, Inc.USD 21.66▲ 2.41%
LPROOpen Lending CorporationUSD 3.15▲ 0.32%
ADUSAddus HomeCare CorporationUSD 114.55▲ 2.83%
RPAYRepay Holdings CorporationUSD 3.8▲ 3.83%
SIBNSI-BONE, Inc.USD 16.62▼ 0.54%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:52 UTC. This page is informational and not investment advice.